Harinder Gill

3.3k total citations
89 papers, 1.4k citations indexed

About

Harinder Gill is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Harinder Gill has authored 89 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 30 papers in Genetics and 29 papers in Molecular Biology. Recurrent topics in Harinder Gill's work include Acute Myeloid Leukemia Research (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers) and Retinoids in leukemia and cellular processes (12 papers). Harinder Gill is often cited by papers focused on Acute Myeloid Leukemia Research (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers) and Retinoids in leukemia and cellular processes (12 papers). Harinder Gill collaborates with scholars based in Hong Kong, China and United States. Harinder Gill's co-authors include Yok‐Lam Kwong, Eric Tse, Yu‐Yan Hwang, Thomas S. Y. Chan, Ching‐Lung Lai, James Fung, Anskar Y.H. Leung, Wai‐Kay Seto, Man‐Fung Yuen and Raymond Liang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hepatology.

In The Last Decade

Harinder Gill

82 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harinder Gill Hong Kong	20	454	375	340	291	282	89	1.4k
Dominique Challine France	18	267 0.6×	344 0.9×	103 0.3×	199 0.7×	249 0.9×	34	1.1k
G. R. Buchanan United States	13	206 0.5×	482 1.3×	336 1.0×	202 0.7×	120 0.4×	22	1.2k
Paul J. Healey United States	11	870 1.9×	233 0.6×	144 0.4×	63 0.2×	311 1.1×	29	1.9k
Akiko Hori Japan	21	288 0.6×	302 0.8×	284 0.8×	49 0.2×	294 1.0×	61	1.3k
Gary Chan United States	22	562 1.2×	302 0.8×	119 0.3×	42 0.1×	501 1.8×	58	2.4k
Philipp Hemmati Germany	21	101 0.2×	366 1.0×	567 1.7×	111 0.4×	374 1.3×	55	1.3k
Kimikazu Matsumoto Japan	20	140 0.3×	567 1.5×	270 0.8×	58 0.2×	237 0.8×	122	1.3k
Josep Antoni Bombí Spain	19	305 0.7×	97 0.3×	153 0.5×	184 0.6×	335 1.2×	66	1.3k
Azhar Ansari United Kingdom	20	355 0.8×	224 0.6×	256 0.8×	198 0.7×	102 0.4×	51	1.7k
Hui Xie China	21	324 0.7×	58 0.2×	332 1.0×	275 0.9×	379 1.3×	95	1.5k

Countries citing papers authored by Harinder Gill

Since Specialization

Citations

This map shows the geographic impact of Harinder Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harinder Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harinder Gill more than expected).

Fields of papers citing papers by Harinder Gill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harinder Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harinder Gill. The network helps show where Harinder Gill may publish in the future.

Co-authorship network of co-authors of Harinder Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Harinder Gill. A scholar is included among the top collaborators of Harinder Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harinder Gill. Harinder Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gill, Harinder. (2024). Adding the epigenomic signature to the prognostic jigsaw of myelodysplastic neoplasm?. British Journal of Haematology. 204(5). 1577–1578. 1 indexed citations

Sugimoto, Yuka, Eran Zimran, Yoshimitsu Shimomura, et al.. (2024). A Phase 3, Randomized, Double-Blind, Active-Comparator-Controlled Study of Bomedemstat Versus Hydroxyurea in Patients with Essential Thrombocythemia Naïve to Cytoreductive Therapy. Blood. 144(Supplement 1). 4569.3–4569.3.

Chan, Kwok Ying, Desmond Y. H. Yap, & Harinder Gill. (2023). Rethinking Palliative Care in Psychiatry. JAMA Psychiatry. 80(11). 1089–1089. 4 indexed citations

Gill, Harinder, Garret M. K. Leung, Melissa Ooi, et al.. (2023). Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group. Clinical and Experimental Medicine. 23(8). 4199–4217.

Yim, Rita, Paul Lee, Garret M. K. Leung, et al.. (2023). Allogeneic haematopoietic stem cell transplantation for myelofibrosis: prognostic indicators and the role of JAK2V617F measurable-residual disease monitoring by droplet-digital polymerase chain reaction. Annals of Hematology. 102(9). 2517–2527. 1 indexed citations

Lee, Paul, et al.. (2022). Single-Nucleotide Variations, Insertions/Deletions and Copy Number Variations in Myelodysplastic Syndrome during Disease Progression Revealed by a Single-Cell DNA Sequencing Platform. International Journal of Molecular Sciences. 23(9). 4647–4647. 2 indexed citations

Lee, Paul, Rita Yim, Jun Li, et al.. (2022). Epigenetic Silencing of PTEN and Epi-Transcriptional Silencing of MDM2 Underlied Progression to Secondary Acute Myeloid Leukemia in Myelodysplastic Syndrome Treated with Hypomethylating Agents. International Journal of Molecular Sciences. 23(10). 5670–5670. 2 indexed citations

Kumana, Cyrus R., et al.. (2022). The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases. Pharmaceutics. 14(9). 1945–1945. 10 indexed citations

Danchaivijitr, Pongwut, Noppacharn Uaprasert, Harinder Gill, et al.. (2022). Safe and effective treatment of venous Thromboembolism associated with Cancer: focus on direct Oral Anticoagulants in Asian patients. Experimental Hematology and Oncology. 11(1). 79–79. 2 indexed citations

10.

Kumana, Cyrus R., Yok‐Lam Kwong, & Harinder Gill. (2022). Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond. Frontiers in Oncology. 12. 1026478–1026478. 4 indexed citations

11.

Gill, Harinder, Margaret L. McKinnon, Bertrand Isidor, et al.. (2020). SETD1B-associated neurodevelopmental disorder. Journal of Medical Genetics. 58(3). 196–204. 19 indexed citations

12.

Gill, Harinder, Garret M. K. Leung, Rita Yim, et al.. (2020). Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting. Hematology. 25(1). 247–257. 11 indexed citations

13.

Kumana, Cyrus R., et al.. (2020). Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside. Frontiers in Oncology. 10. 1294–1294. 14 indexed citations

14.

Gill, Harinder, Rita Yim, Harold K. K. Lee, et al.. (2018). Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study. Cancer. 124(11). 2316–2326. 44 indexed citations

15.

Seto, Wai‐Kay, Yu‐Yan Hwang, Danny Ka‐Ho Wong, et al.. (2016). Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study. Hepatology. 65(5). 1451–1461. 63 indexed citations

16.

Chan, Thomas S. Y., Ian Yeung, Yu‐Yan Hwang, et al.. (2015). Cytomegalovirus retinitis complicating combination therapy with rituximab and fludarabine. Annals of Hematology. 94(6). 1043–1047. 13 indexed citations

17.

Gill, Harinder, Yu‐Yan Hwang, Thomas S. Y. Chan, et al.. (2014). Valganciclovir suppressed Epstein Barr virus reactivation during immunosuppression with alemtuzumab. Journal of Clinical Virology. 59(4). 255–258. 14 indexed citations

18.

Gill, Harinder, et al.. (2012). Rashtriya swsthya bima yojna in India- Implementation and impact. ZENITH International Journal of Multidisciplinary Research. 2(5). 155–173. 3 indexed citations

19.

Gill, Harinder, et al.. (2012). DETERMINANTS OF MIGRATION IN PUNJAB, INDIA: A CASE STUDY OF AMRITSAR DISTRICT. International Journal of Research in Commerce, IT and Management. 1 indexed citations

20.

Hwang, Yu‐Yan, Harinder Gill, Wing‐Yan Au, et al.. (2012). Post‐transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment. Clinical Transplantation. 26(5). 679–683. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact